Samrat Pharmachem Limited (BOM:530125)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Pharmaceutical Chemicals	2.86B	2.82B	3.11B	2.22B	1.79B
Pharmaceutical Chemicals Growth	1.52%	-9.37%	40.06%	23.83%	29.90%
Total	2.86B	2.82B	3.11B	2.22B	1.79B
Total Growth	1.52%	-9.37%	40.06%	23.83%	29.90%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
India	2.79B	2.76B	3.01B	2.11B	1.79B
India Growth	1.15%	-8.32%	42.72%	17.64%	29.90%
Outside India	69.24M	58.08M	98.36M	109.81M	-
Outside India Growth	19.21%	-40.95%	-10.42%	-	-
Total	2.86B	2.82B	3.11B	2.22B	1.79B
Total Growth	1.52%	-9.36%	40.09%	23.77%	29.90%

Source: S&P Global Market Intelligence.